Track topics on Twitter Track topics that are important to you
DGAP-News: MPH Health Care AG / Key word(s): Final Results/Sustainability
MPH Health Care AG: Significant dividend increase from 0.12 EUR to 0.20 EUR per share approved
- Dividend yield at 4 %
Berlin, July 13, 2018: The shareholders of MPH Health Care AG (ISIN: DE000A0L1H32) approved the proposed dividend increase for fiscal 2017 from 0.12 EUR to 0.20 EUR per share at the annual general meeting. The dividend yield of the investment company is currently at around 4 % (Xetra closing price on July 12th: 5.04 EUR).
All other agenda items were also approved in Berlin with a majority of over 99%.
"With our focus on investments in the German healthcare market, we are benefiting from the positive market developments," says Patrick Brenske, CEO of MPH. "Our listed investments HAEMATO AG, M1 Kliniken and CR Capital Real Estate are performing very well. We are therefore confident that we will be able to distribute an attractive dividend in the coming years as well".
In addition to the attractive dividend yield, MPH also has a high net asset value (NAV). As of March 31, 2018, this was 6.25 EUR per share.
The voting results of the annual general meeting of MPH Health Care are available at www.mph-ag.de/en/investor-relations
About MPH Health Care AG:
MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.
Key figures for the MPH Health Care AG share:
Patrick Brenske, Management Board
|Company:||MPH Health Care AG|
|Grünauer Straße 5|
|Phone:||030 / 897 30 86 60|
|Fax:||030 / 897 30 86 69|
|Listed:||Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...